methyldopa has been researched along with Bile Duct Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvaro, D; Battisti, G; Benedetti, A; Bernuzzi, F; Carpino, G; Coufal, M; DeMorrow, S; Frampton, GA; Franchitto, A; Gaudio, E; Invernizzi, P; Marzioni, M; Onori, P; Ramirez, JC | 1 |
| Bengtsson, L; Brodén, G | 1 |
2 other study(ies) available for methyldopa and Bile Duct Cancer
| Article | Year |
|---|---|
Increased local dopamine secretion has growth-promoting effects in cholangiocarcinoma.
Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Dopamine; Humans; Male; Methyldopa; Mice; Mice, Inbred BALB C; Xenograft Model Antitumor Assays | 2010 |
Biliary carcinoma associated with methyldopa therapy.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemistry; Common Bile Duct Neoplasms; Female; Hepatic Duct, Common; Humans; Liver; Male; Methyldopa; Middle Aged; Models, Theoretical; Retrospective Studies | 1980 |